Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

about

A semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons.

P2860

Q30582733-C4F7E552-FF27-4820-B1D9-FF784D0ECA0B

P2860

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

Item

http://www.wikidata.org/entity/Q38912261

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Immunotherapy for the treatmen ...... au, which is the right target?

@en

type

Item

label

Immunotherapy for the treatmen ...... au, which is the right target?

@en

prefLabel

Immunotherapy for the treatmen ...... au, which is the right target?

@en

P1476

Immunotherapy for the treatmen ...... au, which is the right target?

@en

P2093

Diana L Castillo-Carranza

http://www.w3.org/2001/XMLSchema#string

Marcos J Guerrero-Muñoz

http://www.w3.org/2001/XMLSchema#string

Rakez Kayed

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

Active and passive immunotherapy for neurodegenerative disorders

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

Reversible memory loss in a mouse transgenic model of Alzheimer's disease

P304

19-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/ITT.S40131

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27471697

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4918231

http://www.w3.org/2001/XMLSchema#string

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

about

P2860

P2860

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932